 Corporate and Clinical Presentations to Highlight Companys Gene Therapies for Cancer and Diabetes AUSTIN, Texas , Oct. 7, 2022 PRNewswire -- Genprex, Inc. Genprex or the Company NASDAQ: GNPX, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Companys participation in the following upcoming investor and industry conferences to be held in October 2022. Event: Dawson James Securities Annual Small Cap Growth Conference Conference Date: October 12, 2022 Presentation Date: October 12, 2022 Presentation Time: 9:00 a.m. 